Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Gold (chrysotherapy)

3

I.b Pneumonitis (ILD)

3
Last update : 05/05/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Aurothiopropanosulfonate
3

Publications

[Gold salt-induced lung disease].
Archivos de bronconeumologia 2004 Nov;40;540 2004 Nov
Gold-induced pneumonitis: computed tomography findings in a patient with rheumatoid arthritis.
Rheumatology (Oxford, England) 2001 Jun;40;712-4 2001 Jun
[Pulmonary toxicity of gold salts].
Medicina 1991;51;59-61 1991
Gold-induced hypersensitivity pneumonitis in a patient with rheumatoid arthritis.
Clinical and experimental rheumatology 1989;7;89-90 1989
Diffuse interstitial lung disease associated with hypersensitivity to gold salt.
Clinical and experimental rheumatology 1985;3;181-2 1985
Gold-induced lung disease.
Postgraduate medical journal 1983 Jun;59;368-70 1983 Jun
Reversal of progressive, life-threatening gold hypersensitivity pneumonitis by corticosteroids.
The American journal of medicine 1981 Nov;71;908-12 1981 Nov
[Pulmonary side effects of gold treatment].
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete 1981 Dec 15;36;969-72 1981 Dec 15

Powered by

  • ^
  • Contact
  • Cookies
  • About